Electrophysiology issues and heart failure in congenital heart disease

Heart Failure in Congenital Heart Disease: From Fetus to Adult

Volumn , Issue , 2011, Pages 155-172

  Ceresnak, Scott R ^a   Dubin, Anne M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879500637     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84996-480-7_8     Document Type: Chapter

References (99)

1. Steinberger J, Haines HC, Shumway SJ, Bolman RM, 3rd, Rocchini AP, Braunlin EA. Outcome after referral for pediatric transplantation. J Heart Lung Transplant. 1993;12: 766-769.
2. Rosenthal DN, Dubin AM, Chin C, Falco D, Gamberg P, Bernstein D. Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. J Heart Lung Transplant. 2000;19:751-755.
3. Nield LE, McCrindle BW, Bohn DJ et al. Outcomes for children with cardiomyopathy awaiting transplantation. Cardiol Young. 2000;10:358-366.
4. Morrow WR, Frazier E, Naftel DC. Survival after listing for cardiac transplantation in children. Prog Pediatr Cardiol. 2000;11:99-105.
5. Gillette PC, Yeoman MA, Mullins CE, McNamara DG. Sudden death after repair of tetralogy of Fallot. Electrocardiographic and electrophysiologic abnormalities. Circulation. 1977;56: 566-571.
6. Friedman RA, Moak JP, Garson A, Jr. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol. 1991;18:152-156.
7. Gatzoulis MA, Balaji S, Webber SA et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975-981.
8. Griffin ML, Hernandez A, Martin TC et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol. 1988;11:139-144.
9. Hayes CJ, Gersony WM. Arrhythmias after the Mustard operation for transposition of the great arteries: a long-term study. J Am Coll Cardiol. 1986;7:133-137.
10. Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol. 1991;68:365-369.
11. Franz MR, Bode F. Mechano-electrical feedback underlying arrhythmias: the atrial fibrillation case. Prog Biophys Mol Biol. 2003;82:163-174.
12. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89:724-730.
13. Zeppenfeld K, Schalij MJ, Bartelings MM et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation. 2007;116:2241-2252.
14. Sanchez-Quintana D, Climent V, Ho SY, Anderson RH. Myoarchitecture and connective tissue in hearts with tricuspid atresia. Heart. 1999;81:182-191.
15. Dyckner T, Wester PO. Potassium/magnesium depletion in patients with cardiovascular disease. Am J Med. 1987;82:11-17.
16. Wiles HB, Gillette PC, Harley RA, Upshur JK. Cardiomyopathy and myocarditis in children with ventricular ectopic rhythm. J Am Coll Cardiol. 1992;20:359-362.
17. Samet P, Bernstein WH, Nathan DA, Lopez A. Atrial Contribution to Cardiac Output in Complete Heart Block. Am J Cardiol. 1965;16:1-10.
18. Ko JK, Deal BJ, Strasburger JF, Benson DW, Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69:1028-1032.
19. Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A. Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation. 1993;88: 282-295.
20. Fananapazir L, Tracy CM, Leon MB et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation. 1989;80: 1259-1268.
21. Vacca JB, Bussmann DW, Mudd JG. Ebstein's anomaly; complete review of 108 cases. Am J Cardiol. 1958;2:210-226.
22. Abrams D, Schilling R. Mechanism and mapping of atrial arrhythmia in the modified Fontan circulation. Heart Rhythm. 2005;2:1138-1144.
23. Gillette PC, Kugler JD, Garson A, Jr., Gutgesell HP, Duff DF, McNamara DG. Mechanisms of cardiac arrhythmias after the Mustard operation for transposition of the great arteries. Am J Cardiol. 1980;45:1225-1230.
24. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation. 1995;91:2214-2219.
25. Deal BJ, Mavroudis C, Backer CL. Arrhythmia management in the Fontan patient. Pediatr Cardiol. 2007;28:448-456.
26. Vetter VL, Tanner CS, Horowitz LN. Electrophysiologic consequences of the Mustard repair of d-transposition of the great arteries. J Am Coll Cardiol. 1987;10:1265-1273.
27. Gewillig M, Wyse RK, de Leval MR, Deanfield JE. Early and late arrhythmias after the Fontan operation: predisposing factors and clinical consequences. Br Heart J. 1992;67:72-79.
28. Manning PB, Mayer JE, Jr., Wernovsky G, Fishberger SB, Walsh EP. Staged operation to Fontan increases the incidence of sinoatrial node dysfunction. J Thorac Cardiovasc Surg. 1996;111:833-839; discussion 839-840.
29. Shah MJ, Nehgme R, Carboni M, Murphy JD. Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the fontan procedure. Pacing Clin Electrophysiol. 2004;27:949-954.
30. Gelatt M, Hamilton RM, McCrindle BW et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol. 1997;29:194-201.
31. Vetter VL, Tanner CS. Electrophysiologic consequences of the arterial switch repair of d-transposition of the great arteries. J Am Coll Cardiol. 1988;12:229-237.
32. Packer DL, Bardy GH, Worley SJ et al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol. 1986;57:563-570.
33. Horenstein MS, Saarel E, Dick M, Karpawich PP. Reversible symptomatic dilated cardiomyopathy in older children and young adolescents due to primary non-sinus supraventricular tachyarrhythmias. Pediatr Cardiol. 2003;24:274-279.
34. Walsh EP, Saul JP, Hulse JE et al. Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation. 1992;86:1138-1146.
35. Ozcan C, Jahangir A, Friedman PA et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 2001;344:1043-1051.
36. Khairy P, Harris L, Landzberg MJ et al. Implantable cardioverter- defibrillators in tetralogy of Fallot. Circulation. 2008;117:363-370.
37. Minakata K, Dearani JA, O'Leary PW, Danielson GK. Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: early and late results. Ann Thorac Surg. 2005;80:1424-1429; discussion 1429-1430.
38. Sharma JR, Sathanandam S, Rao SP, Acharya S, Flood V. Ventricular tachycardia in acute fulminant myocarditis: medical management and follow-up. Pediatr Cardiol. 2008;29: 416-419.
39. Hoffman TM, Wernovsky G, Atz AM et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003;107:996-1002.
40. Bossaert L, Van Hoeyweghen R. Bystander cardiopulmonary resuscitation (CPR) in out-ofhospital cardiac arrest. The Cerebral Resuscitation Study Group. Resuscitation. 1989;17(suppl): S55-S69; discussion S199-S206.
41. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med. 1989;321:406-412.
42. Fish FA, Gillette PC, Benson DW, Jr. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol. 1991;18:356-365.
43. Perry JC, Knilans TK, Marlow D, Denfield SW, Fenrich AL, Friedman RA. Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. J Am Coll Cardiol. 1993;22:95-98.
44. Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J. 1980;100:1063-1069.
45. Friedman RA, Walsh EP, Silka MJ et al. NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Report of the writing committee. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol. 2002;25:1000-1017.
46. Van Hare GF, Lesh MD, Stanger P. Radiofrequency catheter ablation of supraventricular arrhythmias in patients with congenital heart disease: results and technical considerations. J Am Coll Cardiol. 1993;22:883-890.
47. Morwood JG, Triedman JK, Berul CI et al. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm. 2004;1:301-308.
48. Thornton AS, Janse P, Alings M et al. Acute success and short-term follow-up of catheter ablation of isthmus-dependent atrial flutter; a comparison of 8 mm tip radiofrequency and cryothermy catheters. J Interv Card Electrophysiol. 2008;21:241-248.
49. Triedman JK, Bergau DM, Saul JP, Epstein MR, Walsh EP. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997;30:1032-1038.
50. Kanter RJ, Papagiannis J, Carboni MP, Ungerleider RM, Sanders WE, Wharton JM. Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries. J Am Coll Cardiol. 2000;35: 428-441.
51. Van Hare GF, Lesh MD, Ross BA, Perry JC, Dorostkar PC. Mapping and radiofrequency ablation of intraatrial reentrant tachycardia after the Senning or Mustard procedure for transposition ofthe great arteries. Am J Cardiol. 1996;77:985-991.
52. Misaki T, Tsubota M, Watanabe G et al. Surgical treatment of ventricular tachycardia after surgical repair of tetralogy of Fallot. Relation between intraoperative mapping and histological findings. Circulation. 1994;90:264-271.
53. Triedman JK, Jenkins KJ, Colan SD, Saul JP, Walsh EP. Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. J Cardiovasc Electrophysiol. 1997;8:259-270.
54. Triedman JK, Saul JP, Weindling SN, Walsh EP. Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation. 1995;91: 707-714.
55. Mavroudis C, Backer CL, Deal BJ, Johnsrude CL. Fontan conversion to cavopulmonary connection and arrhythmia circuit cryoblation. J Thorac Cardiovasc Surg. 1998;115:547-556.
56. Zahka KG, Horneffer PJ, Rowe SA et al. Long-term valvular function after total repair of tetralogy of Fallot. Relation to ventricular arrhythmias. Circulation. 1988;78:III14-III19.
57. Therrien J, Siu SC, Harris L et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation. 2001;103:2489-2494.
58. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997;337:1576-1583.
59. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
60. Hamilton RM, Dorian P, Gow RM, Williams WG. Five-year experience with implantable defibrillators in children. Am J Cardiol. 1996;77:524-526.
61. Dubin AM, Berul CI, Bevilacqua LM et al. The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation. J Card Fail. 2003;9:375-379.
62. Silka MJ, Kron J, Dunnigan A, Dick M, 2nd. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation. 1993;87:800-807.
63. Berul CI, Van Hare GF, Kertesz NJ et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685-1691.
64. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004;15:72-76.
65. Sandner SE, Wieselthaler G, Zuckermann A et al. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation. 2001;104:I171-I176.
66. Schmidinger H. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy? Am J Cardiol. 1999;83:151D-157D.
67. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998;32:245-251.
68. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231-237.
69. Chandar JS, Wolff GS, Garson A, Jr. et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am J Cardiol. 1990;65:655-661.
70. Harrison DA, Harris L, Siu SC et al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol. 1997;30:1368-1373.
71. Hokanson JS, Moller JH. Significance of early transient complete heart block as a predictor of sudden death late after operative correction of tetralogy of Fallot. Am J Cardiol. 2001;87: 1271-1277.
72. Khairy P, Landzberg MJ, Gatzoulis MA et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation. 2004;109:1994-2000.
73. Sarkar D, Bull C, Yates R et al. Comparison of long-term outcomes of atrial repair of simple transposition with implications for a late arterial switch strategy. Circulation. 1999;100: II176-II181.
74. Puley G, Siu S, Connelly M et al. Arrhythmia and survival in patients >18 years of age after the mustard procedure for complete transposition of the great arteries. Am J Cardiol. 1999;83: 1080-1084.
75. Dos L, Teruel L, Ferreira IJ et al. Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart. 2005;91:652-656.
76. Kammeraad JA, van Deurzen CH, Sreeram N et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol. 2004;44:1095-1102.
77. Link MS, Hill SL, Cliff DL et al. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol. 1999;83:263-266, A5-A6.
78. Klug D, Vaksmann G, Jarwe M et al. Pacemaker lead infection in young patients. Pacing Clin Electrophysiol. 2003;26:1489-1493.
79. Fortescue EB, Berul CI, Cecchin F, Walsh EP, Triedman JK, Alexander ME. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004;1:150-159.
80. Grimm W, Menz V, Hoffmann J et al. Complications of third-generation implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol. 1999;22:206-211.
81. Figa FH, McCrindle BW, Bigras JL, Hamilton RM, Gow RM. Risk factors for venous obstruction in children with transvenous pacing leads. Pacing Clin Electrophysiol. 1997;20: 1902-1909.
82. Bar-Cohen Y, Berul CI, Alexander ME et al. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol. 2006;17:754-759.
83. Stephenson EA, Batra AS, Knilans TK et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006;17:41-46.
84. Bauersfeld U, Tomaske M, Dodge-Khatami A, Rahn M, Kellenberger CJ, Pretre R. Initial experience with implantable cardioverter defibrillator systems using epicardial and pleural electrodes in pediatric patients. Ann Thorac Surg. 2007;84:303-305.
85. Kriebel T, Ruschewski W, Gonzalez y Gonzalez M et al. ICD Implantation in infants and small children: the extracardiac technique. Pacing Clin Electrophysiol. 2006;29:1319-1325.
86. Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation. 1989;79:845-853.
87. Duncan AM, Francis DP, Gibson DG, Henein MY. Limitation of exercise tolerance in chronic heart failure: distinct effects of left bundle-branch block and coronary artery disease. J Am Coll Cardiol. 2004;43:1524-1531.
88. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
89. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350: 2140-2150.
90. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-880.
91. Epstein AE, Dimarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for devicebased therapy of cardiac rhythm abnormalities. Heart Rhythm. 2008;5:e1-e62.
92. Alexander ME, Berul CI, Fortescue EB et al. Who is eligible for cardiac resyncrhonizationtherapy in pediatric cardiology? Heart Rhythm. 2004;1:S122.
93. Janousek J, Tomek V, Chaloupecky VA et al. Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol. 2004;44:1927-1931.
94. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation. 2003;107:2287-2289.
95. Strieper M, Karpawich P, Frias P et al. Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. Am J Cardiol. 2004;94:1352-1354.
96. Bacha EA, Zimmerman FJ, Mor-Avi V et al. Ventricular resynchronization by multisite pacing improves myocardial performance in the postoperative single-ventricle patient. Ann Thorac Surg. 2004;78:1678-1683.
97. Zimmerman FJ, Starr JP, Koenig PR, Smith P, Hijazi ZM, Bacha EA. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg. 2003;75:1775-1780.
98. Cecchin F, Frangini PA, Brown DW et al. Cardiac Resynchronization Therapy (and Multisite Pacing) in Pediatrics and Congenital Heart Disease: Five Years Experience in a Single Institution. J Cardiovasc Electrophysiol. 2008;58-65.
99. Dubin AM, Janousek J, Rhee E et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46: 2277-2283.